Contact Us / Sitemap / Directions / Patients and Visitors / Career Opportunities / Medical Staff
pay your hospital bill pay your doctor's bill paying for your care
Winthrop University Hospital

Stage IB-IIIA Non-Small Cell Lung Cancer


This phase III study is for patients who have non small cell lung cancer. The pupose of this study is to find out if adding the new drug Bevacizumab (avastin) to chemotherapy improves the chance of a cure for patients who have had surgery for the removal of their lung cancer.


The study will evaluate the effects (good and bad) of a standard combination of chemotherapy drugs when given with and without the new drug, bevacizumab. The chemotherapy regimen drugs are: Cisplatin and Vinorelbine, Cisplatin and Docetaxel, Cisplatin and Gemcitabine.


Patients must undergo study specific types of lung surgery to remove the tumor with study specific staging. Patients must be recovering well from their lung surgery at least 6 weeks and up to 12 weeks before starting their study medication.

Principal Investigator

Jeffrey Schneider MD




Other Contact
Contact Us / Sitemap / Directions / Career Opportunities / Financial Assistance / Policies
Winthrop-University Hospital
259 First Street | Mineola NY 11501 | 516-663-0333

This site provides information as a resource. It is not a substitute for professional medical advice.
Always consult a physician or healthcare provider for treatment and guidance toward good health.
Copyright © 2015 Winthrop-University Hospital. All rights reserved.
Web site by: Long Island Web Design